T HE remarkable technics of modern cardiac surgery, that permit restoration of normal anatomic and hemodynamic relationships in hearts with septal defects, have created some problems in the identification and control of postoperative arrhythmias. It is not surprising that auriculotomy and ventriculotomy with the closure of septal defects might produce significant disturbances of car- .diae rhythm in view of the proximity of some of the specialized conducting tissues to these defects. Previous reports of surgically treated patients do not stress the occurrence of postoperative arrhythmias. This report is a review of the cardiac arrhythmias that have occurred in a series of 110 patients with atrial (62) and ventricular (48) septal defects operated on before January 1, 1958. A significant proportion of these patients had major disturbances of rhythm in the immediate postoperative period, and in the case of patients with atrial septal defects, various paroxysmal arrhythmias occurred during convalescence. Our patients were monitored electrocardiographically during surgery, at frequent intervals during the first postoperative day, and as often as indicated thereafter.
ATRIAL SEPTAL DEFECTS All but 2 of the patients with atrial septal defects were operated on under hypothermic This study was supported in part by a grant from the Iowa Heart Association.
conditions. Rapid surface cooling was indueed by immersion of the anesthetized patient in a tub filled with cracked ice and water. Cardiotomy was performed during occlusion of the large vessels of the in-flow and out-flow tracts to permit operation in a bloodless field. Two periods of circulatory occlusion were used when valvular pulmonic stenosis was associated with an atrial septal defect. Pulmonic valvuloplasty was performed during the first and shorter period of occlusion; then the heart was allowed to recover before the second period of occlusion for repair of the atrial septal defect. A modified atrioseptopexy was done in 2 A-V heart block 6 weeks and 5 months after operatioii. They have not required treatment.
Nodal rhythm without tachycardia has been a relatively common finding. It occurred in 5 patients who had no other arrhythmia, and was preseiit intermittently in 3 more who also had other arrhythmias. It has persisted from 1 day to niore than 1 year after operatiOlil.
The explanation for the supraventricular ari hythmias is unknown. The common denominators have been hypothermia, circulatory occlusion, the incision of the wall of the right atrium, and the placement of sutures for the closure of the atrial defects. There appears to be no correlation with the degree of body ('ooling heart in conjunction with a pump oxygenator was used 11 times.
Ventricular fibrillation occurred in 9 patients during closure of the ventricular septal defects. Sinus rhythm was restored easily in all but 1 who died. This arrhythmia occurred in 8 patients operated on with the pump oxygenator, in 3 of whom potassium arrest also was used. The other patient with ventricular fibrillation, whose defect was repaired under hypothermia, was easily defibrillated. Coronary air embolism was thought to be responsible for ventricular fibrillation in 2 patients with potassium arrest. In one, poor contractions were observed first in an area over the free wall of the left ventricle although the remainder of the heart contracted normally; ventricular fibrillation developed a short time later. Vigorous fibrillary contractions developed in the area of the left ventricle that had previously been atonic after cardiac massage, and electric countershock reestablished regular ventricular contractions.
Eight patients died, 1 from ventricular fibrillation at the time of surgery, and 7 others within 48 hours after operation. One, with an isolated ventricular septal defect and severe pulmonary hypertension (75/36 mm. Hg), and 2, who had an atrial septal defect and pulmonic stenosis as well as a ventricular septal defect, developed complete A-V heart block that persisted until death. Arrhythmias were not clearly related to the deaths of the other 4 patients, although supraventricular Experiments were done on the fluxes of sodium and potassium across the human red cell membranes to determine whether the glycosides act on the transport mechanism by interfering with the energy mechanism during the "sodium pumlp" or by interfering with the carrier mechanism in the membrane of the cell. To test whether the action of the cardiac glycosides is one of interference with the transmission of energy to the "pumip," experiments were done to study the fluxes in the presence and absence of glucose and with or without the inhibitor, digoxin. The potassium influx was related to the level of external potassium. This was measured by radioactive potassium uptake in red cells. With a fixed external potassium level a given dose of digoxin caused a given degree of inhibition of uptake of potassium. When glucose was removed fronm the experimental system, the effect of digoxin was unchanged. The efflux of labeled potassium from the cells was not influenced by the presence of glucose or digoxin. The efflux of sodium from cells on the other hand was greatly influenced when digoxin was added to the system. Sodium efflux was reduced by 50 per cent in this way, yet the efflux remained unaffected by glucose deprivation. The influx of labeled sodium was reduced 40 per cent when digoxin was added to the external environment, but the influx of labeled sodium was uninfluenced by the absence of glucose in the external environmnent.
The conclusions drawn from these experiments are that the action of cardiac glycosides cannot be explained by supposing that the drugs interfere with the energy supply to "pump"; their action must interfere with the mechanism by which ions penetrate the membrane. The author further studied the effect of substances of like chemical configuration to the cardiac glycosides on these fluxes. From these experiments it was possible to define certain molecular features that are necessary for such action on ion fluxes. This study shows that the cardiac glycoside competes with potassium ions for a site on the cell membrane where penetration of the ion occurs. From a study of these molecular movements, it is estimated that there are about 1,000 such sites on a red cell membrane. HARVEY
